FDA PMA FDA Class 3 Approved 🇺🇸 United States

Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma

PMA: P830063 · Supplement: S013 · Decision Feb 12, 2021
Classifications
1
FEI Numbers
5
Registration Numbers
5

Basic Information

Device Name
Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma
Trade Name
Prismaflex TPE2000 Set
PMA Number
P830063
Supplement Number
S013
Device Class
FDA Class 3
Product Code
MDP
Generic Name
Separator for therapeutic purposes, membrane automated blood cell/plasma
Medical Specialty
Unknown
Advisory Committee
Gastroenterology, Urology
Decision
Approved
Decision Code
APPR
Decision Date
February 12, 2021
Date Received
September 23, 2019
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for a change in the parting line on the blood ports of the support plate of the manufacturing mold.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MDP Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma